Alcaftadine

Drug Profile

Alcaftadine

Alternative Names: Lastacaft; R-89674

Latest Information Update: 25 Sep 2015

Price : $50

At a glance

  • Originator Vistakon Pharmaceuticals
  • Developer Allergan; Vistakon Pharmaceuticals
  • Class Anti-inflammatories; Antiallergics; Benzazepines; Piperidines; Small molecules
  • Mechanism of Action Histamine H1 receptor antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Marketed Allergic conjunctivitis

Most Recent Events

  • 25 Sep 2015 Launched for Allergic conjunctivitis in South Korea (Ophthalmic)
  • 01 Sep 2015 Registered for Allergic conjunctivitis in South Korea (Ophthalmic)
  • 28 Jul 2010 Registered for Allergic conjunctivitis in USA (Ophthalmic)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top